APC & VLE Therapeutics, the Irish Multinational group, announce €100M expansion and 300 new jobs to establish ‘The Medicine Accelerator Campus’ in Cherrywood, Dublin

We’re delighted to announce that APC has received Deloitte's 'Ireland's Best Managed Company Award' at a gala in Dublin on September 14, 2023. This award is given based on a company's overall success, including its company culture, management strength, capacity for innovation, strategic initiatives, sustainability, and financial performance.

APC and VLE founders Mark Barrett and Brian Glennon received the 2022 Pharma Leader award, recognising growth from 2 to 270 staff and development of over 400 medicines.

Learn more about Nobel-prize winner Barry Sharpless and his impact on modern chemistry.

APC argues that the US Biotechnology and Biomanufacturing Initiative requires deep process understanding, not just new infrastructure, to build genuine supply chain resilience.

APC's Medicine Accelerator combines a €25M investment, iAchieve® digital platform, and 200+ scientists to accelerate CMC development and regulatory submissions.

APC unveils €25m investment and 120 jobs to accelerate development and manufacture of Covid Vaccines and Advanced Therapeutics.

Industry Veteran Brett Huff has joined APC to head up our First-in-Class Digital Strategy for process development.

APC marks Rare Disease Day, highlighting that only 5% of 7,000 known rare diseases have treatments, underscoring the urgency of pharma process development.

Taoiseach Micheál Martin visited APC's Dublin facility to review Ireland's COVID-19 vaccine development programme in partnership with Australian biotech firm Vaxine.